Integrated Genomics, Inc. Release: Genencor International, Inc. Licenses The ERGO(TM) Genomics Platform For Microbial Production Of Enzymes And Other Bioproducts’

CHICAGO--(BUSINESS WIRE)--Integrated Genomics announced today that Genencor, the biotechnology division of Danisco A/S that develops innovative enzymes and bio-products, has licensed the ERGO™ bioinformatics software system to characterize and optimize microbial products used in reducing the environmental impact of the cleaning, textiles, fuel and chemical industries. ERGO is a powerful software platform for analyzing genome sequences and performing gene annotations, metabolic reconstructions, and other gene analyses and comparisons.

MORE ON THIS TOPIC